International Conference on
Autism Research and Neurodevelopmental Disorders
November 11–12, 2027 | Amsterdam, Netherlands
CPD
Amsterdam, Netherlands
Phone: +44 2045874848
WhatsApp: +44 7383507342

Biomarkers, Neuroimaging, and Digital Diagnostics

Biomarkers, Neuroimaging, and Digital Diagnostics

Biomarkers, advanced neuroimaging, and digital diagnostic technologies are improving the understanding of autism by providing objective measures of brain development, biological processes, and behavioral characteristics. These approaches support research into earlier identification, disease mechanisms, and more precise clinical assessment.

This track focuses on studies investigating imaging techniques, molecular biomarkers, wearable technologies, digital assessments, and innovative diagnostic tools. It encourages multidisciplinary research that enhances diagnostic accuracy and supports individualized clinical decision-making.

  • Molecular and Genetic Biomarkers
  • Neuroimaging Technologies (MRI, fMRI, PET, EEG)
  • Digital Biomarkers and Wearable Devices
  • Eye-Tracking and Behavioral Analytics
  • Electrophysiological Assessment
  • Early Diagnostic Technologies
  • Multi-Modal Diagnostic Approaches
  • Clinical Validation of Digital Tools

Related Sessions

Tags